Ignite Creation Date:
2024-05-05 @ 5:25 PM
Last Modification Date:
2024-10-26 @ 9:32 AM
Study NCT ID:
NCT00457028
Status:
COMPLETED
Last Update Posted:
2011-06-08
First Post:
2007-04-03
Brief Title:
Efficacy of Treatment for Obsessive Compulsive Disorder
Sponsor:
University of British Columbia
Organization:
University of British Columbia
Study Overview
Official Title:
Efficacy of Treatment for Obsessive Compulsive Disorder
Status:
COMPLETED
Status Verified Date:
2011-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of these questionnaires is to give us an overview of how OCD has affected your life and perhaps also to give us some clues about things that may have set you up to experience OCD
Detailed Description:
For us to evaluate the efficacy of our treatment programs we are interested in your responses before and after treatment We use two methods to evaluate the efficacy of our treatments questionnaires and interviews with a member of the Anxiety Disorders Clinic As part of standard clinic procedure each person in the program completes an in-person interview with a staff member who will determine your suitability for treatment If you have received this questionnaire packet it is likely that your concerns will be appropriately addressed in the Anxiety Disorders Clinic The purpose of the questionnaire packet is to assess the severity of your obsessive-compulsive disorder its impact on your functioning and factors that may contribute to the onset or maintenance of your OCD eg depression personal standards We will ask you to complete this questionnaire again when you have completed your treatment along with a brief telephone interview with a staff member of the Anxiety Disorders Clinic
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None